Table 3

Frequency of use of OAP and/or OAC in association with the cardiovascular risk factors
Risk factor OAP or OAC OAP OAC OAP and OAC
n (%) n (%) n (%) n (%)
Pharmacologically treated hypertension 1480 1354 151 25
(50.32%) (46.04%) (5.13%) (0.85%)
Previus myocardial infarct 375 350 35 10
(67.69%) (63.18%) (6.32%) (1.81%)
Previous stroke 261 237 25 1
(61.27%) (55.63%) (5.87%) (0.23%)
History of atrial fibrilation 498 396 117 15
(56.91%) (45.26%) (13.37%) (1.71%)
Coronary heart disease (without myocardial infarct) 426 382 58 14
(61.21%) (54.89%) (8.33%) (2.01%)
Congestive heart failure 341 290 61 10
(64.22%) (54.61%) (11.49%) (1.88%)
Pharmacologically treated diabetes 471 432 43 4
(46.82%) (42.94%) (4.27%) (0.40%)
Pharmacologically treated dyslipidaemia 795 726 86 17
(63.20%) (57.71%) (6.84%) (1.35%)
Current smoker 132 123 10 1
(29.40%) (27.39%) (2.23%) (0.22%)
Overweight/obesity 1278 1159 142 23
(BMI ≥ 25 kg/m2) (38.30%) (34.73%) (4.26%) (0.69%)

Data presented as n (%).

OAP - Oral antiplatelet drugs, OAC - Oral anticoagulant drugs.

Labuz-Roszak et al.

Labuz-Roszak et al. BMC Cardiovascular Disorders 2012 12:98   doi:10.1186/1471-2261-12-98

Open Data